{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:40:29Z","timestamp":1761561629789},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.psychres.2012.02.015","type":"journal-article","created":{"date-parts":[[2012,3,31]],"date-time":"2012-03-31T02:17:20Z","timestamp":1333160240000},"page":"221-226","source":"Crossref","is-referenced-by-count":13,"title":["Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression"],"prefix":"10.1016","volume":"197","author":[{"given":"Judith","family":"Weissman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair","family":"Flint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barnett","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samiran","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Mulsant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Rothschild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2012.02.015_bb0005","first-page":"1","article-title":"Practice guideline for the treatment of patients with major depressive disorder (revision)","volume":"157","author":"American Psychiatric Association","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2012.02.015_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3928\/00485713-20060101-02","article-title":"Pharmacotherapy of major depression with psychotic features: what is the evidence?","volume":"36","author":"Andreescu","year":"2006","journal-title":"Psychiatric Annals"},{"key":"10.1016\/j.psychres.2012.02.015_bb0015","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1176\/ajp.147.9.1203","article-title":"Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression","volume":"147","author":"Anton","year":"1990","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2012.02.015_bb0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/0022-006X.47.2.343","article-title":"Scale for suicide ideation","volume":"47","author":"Beck","year":"1979","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.psychres.2012.02.015_bb0025","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders - Patient Edition (SCID-I\/P)","author":"First","year":"2001"},{"key":"10.1016\/j.psychres.2012.02.015_bb0030","series-title":"Geriatric Consultation Psychiatry","first-page":"267","article-title":"Psychopharmacological management of the medically ill older person","author":"Flint","year":"2001"},{"key":"10.1016\/j.psychres.2012.02.015_bb0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini mental state\": a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.psychres.2012.02.015_bb0040","series-title":"Clinical Global Impressions","first-page":"217","article-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.psychres.2012.02.015_bb0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1016\/j.psychres.2012.02.015_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0163-8343(01)00171-2","article-title":"Predictors of nonresponse to treatment in primary care patients with dysthymia","volume":"24","author":"Katon","year":"2002","journal-title":"General Hospital Psychiatry"},{"key":"10.1016\/j.psychres.2012.02.015_bb0055","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/archpsyc.62.12.1305","article-title":"Dropout rates in placebo-controlled and active control clinical trials of antipsychotic drugs: a meta-analysis","volume":"62","author":"Kemmler","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2012.02.015_bb0060","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/070674379904400904","article-title":"Retention rates in placebo- and nonplacebo-controlled clinical trials of schizophrenia","volume":"44","author":"Labelle","year":"1999","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2012.02.015_bb0065","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.biopsych.2006.05.033","article-title":"for the STOP-PD Study Group. A delusion assessment scale for psychotic major depression: reliability, validity, and utility","volume":"60","author":"Meyers","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2012.02.015_bb0070","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/archgenpsychiatry.2009.79","article-title":"for the STOP-PD Study Group. A double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression - the STOP-PD study","volume":"66","author":"Meyers","year":"2009","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2012.02.015_bb0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-1781(92)90005-N","article-title":"Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale","volume":"41","author":"Miller","year":"1992","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2012.02.015_bb0080","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1532-5415.2002.50206.x","article-title":"Association between medical comorbidity and treatment outcomes in late-life depression","volume":"50","author":"Oslin","year":"2002","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.psychres.2012.02.015_bb0085","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1016\/j.psychres.2012.02.015_bb0095","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0006-3223(02)01747-X","article-title":"Challenges in the treatment of depression with psychotic features","volume":"53","author":"Rothschild","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2012.02.015_bb0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/01.jcp.0000130557.08996.7a","article-title":"A double-blind, randomized study of olanzapine and olanzapine\/fluoxetine combination for major depression with psychotic features","volume":"24","author":"Rothschild","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2012.02.015_bb0100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1176\/ajp.142.4.430","article-title":"The pharmacological treatment of delusional depression","volume":"142","author":"Spiker","year":"1985","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2012.02.015_bb0105","series-title":"Schedule for Affective Disorders and Schizophrenia (third edition)","author":"Spitzer","year":"1979"},{"key":"10.1016\/j.psychres.2012.02.015_bb0110","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/appi.ajp.2007.06071225","article-title":"Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report","volume":"164","author":"Warden","year":"2007","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2012.02.015_bb0120","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1192\/bjp.bp.105.010470","article-title":"Pharmacological treatment for unipolar psychotic depression: systematic review and meta-analysis","volume":"188","author":"Wijkstra","year":"2006","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2012.02.015_bb0115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-0447.2009.01464.x","article-title":"Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine","volume":"121","author":"Wijkstra","year":"2010","journal-title":"Acta Psychiatrica Scandinavia"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178112000972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178112000972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T03:41:14Z","timestamp":1593920474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178112000972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0165178112000972"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2012.02.015","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}